ATE433463T1 - Monospezifische antikörper gegen fibrinogen und fibrinopeptide b - Google Patents

Monospezifische antikörper gegen fibrinogen und fibrinopeptide b

Info

Publication number
ATE433463T1
ATE433463T1 AT98935874T AT98935874T ATE433463T1 AT E433463 T1 ATE433463 T1 AT E433463T1 AT 98935874 T AT98935874 T AT 98935874T AT 98935874 T AT98935874 T AT 98935874T AT E433463 T1 ATE433463 T1 AT E433463T1
Authority
AT
Austria
Prior art keywords
fpb
fibrinopeptide
provides
antibodies
monospecific
Prior art date
Application number
AT98935874T
Other languages
English (en)
Inventor
Bohdan Kudryk
Colvin Redman
Jian-Zhong Zhang
Original Assignee
New York Blood Ct Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Ct Inc filed Critical New York Blood Ct Inc
Application granted granted Critical
Publication of ATE433463T1 publication Critical patent/ATE433463T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/972Modified antibody, e.g. hybrid, bifunctional
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98935874T 1997-07-25 1998-07-22 Monospezifische antikörper gegen fibrinogen und fibrinopeptide b ATE433463T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/900,660 US5876947A (en) 1997-07-25 1997-07-25 Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
PCT/US1998/015059 WO1999005176A1 (en) 1997-07-25 1998-07-22 Monospecific antibody reactive with fibrinogen and fibrinopeptide b

Publications (1)

Publication Number Publication Date
ATE433463T1 true ATE433463T1 (de) 2009-06-15

Family

ID=25412892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98935874T ATE433463T1 (de) 1997-07-25 1998-07-22 Monospezifische antikörper gegen fibrinogen und fibrinopeptide b

Country Status (7)

Country Link
US (1) US5876947A (de)
EP (1) EP1007570B1 (de)
AT (1) ATE433463T1 (de)
AU (1) AU8503898A (de)
DE (1) DE69840895D1 (de)
ES (1) ES2328306T3 (de)
WO (1) WO1999005176A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19910102B4 (de) * 1999-03-08 2006-06-01 Fischer, Markus, Dr.rer.nat. Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben
US20040014158A1 (en) * 1999-03-08 2004-01-22 Adelbert Bacher Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates
US6673561B1 (en) 1999-06-30 2004-01-06 Regents Of The University Of California Diagnostic test for thrombotic or thromboembolic disease
EP1192183A2 (de) * 1999-06-30 2002-04-03 The Regents of the University of California Diagnostiktest für thrombotische oder thromboembolische erkrankungen
US7547285B2 (en) * 2003-02-14 2009-06-16 The Charlotte-Mecklenburg Hospital Authority Device and method for collection of exhaled alveolar breath condensate
US7828741B2 (en) * 2002-12-20 2010-11-09 The Charlotte-Mecklenburg Hospital Authority Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
DE60326988D1 (de) * 2002-12-20 2009-05-14 Charlotte Mecklenburg Hospital Wegwerf-handvorrichtung zum auffangen von ausgeatmetem atemkondensat
CA2529486A1 (en) * 2003-06-18 2004-12-23 Nst Neurosurvival Technologies Ltd. Method for selective targeting of apoptotic cells and small molecule ligands used thereof
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
CA2673296C (en) * 2006-12-29 2012-10-16 Abbott Laboratories Improved assay for immunosuppressant drugs
US20100184680A1 (en) * 2007-09-11 2010-07-22 Dorian Bevec Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43
US8900822B2 (en) 2011-11-21 2014-12-02 Ethicon, Inc. Fibrinogen assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68917797T2 (de) * 1988-06-10 1995-01-05 New York Blood Center Inc Gegen menschliches Fibrinopepid A spezifische monoklonale Antikörper.
JPH03287070A (ja) * 1990-04-03 1991-12-17 Tosoh Corp フィブリノペプタイドBβ↓1‐↓4↓2の測定法

Also Published As

Publication number Publication date
EP1007570B1 (de) 2009-06-10
DE69840895D1 (de) 2009-07-23
EP1007570A1 (de) 2000-06-14
EP1007570A4 (de) 2005-02-23
AU8503898A (en) 1999-02-16
WO1999005176A1 (en) 1999-02-04
ES2328306T3 (es) 2009-11-11
US5876947A (en) 1999-03-02

Similar Documents

Publication Publication Date Title
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
SE9500023D0 (sv) Method of detecting cancer
ATE426018T1 (de) Pca3, pca3-gene und verfahren zu ihrer verwendung
ATE433463T1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
ATE297950T1 (de) Testverfahren und reagenzien zur quantifizierung von hbnp
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
CA2192940A1 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
ATE196804T1 (de) Test für thrombosegefahr
CA2499926A1 (en) Antibody against von willebrand factor cleaving enzyme and assay system using the same
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
JP2002542820A5 (de)
KR870008186A (ko) 면역글로부린 Al(IgAl) 단면 분석에 의한 임질진단방법, 그 시약 및 키트(kit)
Dardik et al. The structure of endothelial cell thrombospondin: Characterization of the heparin‐binding domains
BR9815090A (pt) "moléculas de ácido nucléico correlacionadas com o fenótipo rhesus d fraco"
JP4913034B2 (ja) Adamts13活性検定用抗体及び活性検定方法
DE502004008729D1 (de) Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
CN101074263B (zh) 一种重组抗proteinA单克隆抗体及其制备方法和用途
DE60334408D1 (de) Nsäuren
CN108473567A (zh) Cgrp抗体及其用途
CA2399047A1 (en) Reagents and methods useful for detecting diseases of the breast
ATE158815T1 (de) Hippurikasegen
CA2370519A1 (en) Nucleic acids encoding a mutt domain-containing polypeptide
EP3548899A1 (de) Neuartiger antikörper zur bestimmung der adamts-13-aktivität
Gaffney et al. Monoclonal antibodies against fibrinogen, fibrin and their fragments

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007570

Country of ref document: EP

REN Ceased due to non-payment of the annual fee